Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

doi:10.3748/wjg.v26.i1.70

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9155)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

524

WORD

228

HTML

4987

Figures (1-6)

281

Tables (1-4)

293

Sum=6313

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

994

Download

1848

Sum=2842

Jan 7, 2020 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jan 7, 2020; 26(1): 70-85
Published online Jan 7, 2020. doi: 10.3748/wjg.v26.i1.70

Table 1 Characteristics of the different faecal immunochemical tests evaluated

Ref.	Country	Analytical system for estimation of faecal haemoglobin concentration
Cubiella et al[9], 2016 (DC)	Spain	OC-Sensor: 100%
Rodríguez-Alonso et al[8], 2015	Spain	OC-Sensor: 100%
Cubiella et al[9], 2016 (VC)	Spain	OC-Sensor: 49.7%; OC-Auto 3 Latex 13.8%; FOB Gold 2.4%; Linear i-FOB 34.1%
Overall	Spain	OC-Sensor: 81.8%; OC-Auto 3 Latex 5.0%; FOB Gold 0.9%; Linear i-FOB 12.3%

DC: Derivation cohort; VC: Validation cohort.

Citation: Pin-Vieito N, Iglesias MJ, Remedios D, Rodríguez-Alonso L, Rodriguez-Moranta F, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Cubiella J, on behalf of the COLONPREDICT study investigators. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test. World J Gastroenterol 2020; 26(1): 70-85
URL: https://www.wjgnet.com/1007-9327/full/v26/i1/70.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i1.70